An observational study in Kidney Cancer, sponsored by University Hospital, Bordeaux. Completed at 15 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-09-25.
Sponsored by University Hospital, Bordeaux · Observational
The purpose of the study is to set up the larger prospective study on robotic partial nephrectomy, to describe the characteristics of patients operated for kidney cancer by this surgical procedure and also to determine the modalities of hemostasis in this procedure.
The primary objective of the study is to describe the characteristics of patients operated for kidney cancer by a robotic partial nephrectomy in France (recruiting centers, patient profile, tumor characteristics).
Secondary Objective(s):
Patients operated for kidney cancer by this surgical procedure
Inclusion Criteria:
Exclusion Criteria: None
Robotic partial surgery
Procedure: Robotic partial surgery
Robotic partial surgery
Post-operative complications evaluated according to the Clavien criteria
Per and post-operative transfusion rates
Time frame: From surgery until 1 year of follow up
Post-operative complications evaluated according to the Clavien criteria
Medical or surgical complication rates
Time frame: From surgery until 1 year of follow up
Post-operative complications evaluated according to the Clavien criteria
Clavien's grading
Time frame: From surgery until 1 year of follow up
Post-operative complications evaluated according to the Clavien criteria
Urinary fistula rate
Time frame: From surgery until 1 year of follow up
Post-operative complications evaluated according to the Clavien criteria
Necessity for nephrectomy or re-exploration
Time frame: From surgery until 1 year of follow up
Post-operative complications evaluated according to the Clavien criteria
Length of hospital stay
Time frame: From surgery until 1 year of follow up
Renal function after robotic partial nephrectomy measured by biological parameters
Creatininemia
Time frame: Follow-up during 12 months
Renal function after robotic partial nephrectomy measured by biological parameters
MDRD GFR
Time frame: Follow-up during 12 months
Per-operative modalities of haemostasis procedure
Haemostasis procedure
Time frame: At Surgery
Per-operative modalities of haemostatic agent
Haemostatic agent
Time frame: At Surgery
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Jul 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Bordeaux